IL-17 in obesity and adipogenesis.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMC 3259710)

Published in Cytokine Growth Factor Rev on November 16, 2010

Authors

Mushtaq Ahmed1, Sarah L Gaffen

Author Affiliations

1: University of Pittsburgh, Department of Medicine, Division of Rheumatology & Clinical Immunology, Pittsburgh, PA 15261, USA.

Articles citing this

Metabolic regulation of T lymphocytes. Annu Rev Immunol (2013) 3.67

Obesity, inflammation, and liver cancer. J Hepatol (2011) 2.09

IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol (2011) 1.95

Role of "Western diet" in inflammatory autoimmune diseases. Curr Allergy Asthma Rep (2014) 1.79

IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. Hepatology (2014) 1.69

IL-17 family: cytokines, receptors and signaling. Cytokine (2013) 1.66

Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes (2012) 1.42

CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity. Cell (2015) 1.38

Microbial reprogramming inhibits Western diet-associated obesity. PLoS One (2013) 1.21

Retinoic acid-related orphan receptors α and γ: key regulators of lipid/glucose metabolism, inflammation, and insulin sensitivity. Front Endocrinol (Lausanne) (2013) 1.06

Role of T cells in malnutrition and obesity. Front Immunol (2014) 1.00

IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors. Cytokine (2013) 0.94

Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors. Clin Exp Dermatol (2014) 0.87

Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis. J Biol Chem (2013) 0.87

Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells. Nat Commun (2015) 0.86

Is serum Interleukin-17 associated with early atherosclerosis in obese patients? J Transl Med (2014) 0.86

The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases. BMB Rep (2013) 0.85

High prevalence of nickel allergy in an overweight female population: a pilot observational analysis. PLoS One (2015) 0.79

Childhood obesity: immune response and nutritional approaches. Front Immunol (2015) 0.79

Insulin resistance and serum levels of interleukin-17 and interleukin-18 in normal pregnancy. Immune Netw (2014) 0.78

IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression. Curr Drug Targets (2015) 0.78

Interleukin-17A Gene Expression in Morbidly Obese Women. Int J Mol Sci (2015) 0.77

The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases. Mediators Inflamm (2017) 0.76

Adipocytes, like their progenitors, contribute to inflammation of adipose tissues through promotion of Th-17 cells and activation of monocytes, in obese subjects. Adipocyte (2016) 0.75

MicroRNA-26a-interleukin (IL)-6-IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model. Clin Exp Immunol (2016) 0.75

Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway. Brain Behav Immun (2015) 0.75

CXCL-16, IL-17, and bone morphogenetic protein 2 (BMP-2) are associated with overweight and obesity conditions in middle-aged and elderly women. Immun Ageing (2017) 0.75

CCAAT/Enhancer-binding protein β promotes pathogenesis of EAE. Cytokine (2017) 0.75

The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo. Sci Signal (2017) 0.75

Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition. Genes Nutr (2017) 0.75

Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity. World J Biol Chem (2017) 0.75

Articles cited by this

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 30.22

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol (2005) 27.17

Interleukin-17 family members and inflammation. Immunity (2004) 16.16

Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol (2006) 11.36

Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev (1991) 11.10

The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity (2008) 10.55

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol (2008) 8.43

Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol (2005) 8.39

Obesity, inflammation, and insulin resistance. Gastroenterology (2007) 7.54

Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol (2010) 6.88

Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol (2004) 6.78

Structure and signalling in the IL-17 receptor family. Nat Rev Immunol (2009) 6.38

IL-23 promotes tumour incidence and growth. Nature (2006) 6.30

Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev (2003) 5.57

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95

Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol (2007) 4.90

Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology (2003) 4.28

The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med (2008) 3.68

Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology (2010) 3.51

Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem (2003) 3.41

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med (2007) 2.89

Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab (2000) 2.88

Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol (2004) 2.73

Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology (1999) 2.65

Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) (2008) 2.51

Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc Natl Acad Sci U S A (2005) 2.51

Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice. J Leukoc Biol (2009) 2.38

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol (2010) 2.27

Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A (2000) 2.14

Obesity predisposes to Th17 bias. Eur J Immunol (2009) 2.04

IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine (2007) 1.93

Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc Natl Acad Sci U S A (1986) 1.91

IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol (2008) 1.73

Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci (2008) 1.60

IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci Signal (2009) 1.57

IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ (2009) 1.53

gp130 receptor ligands as potential therapeutic targets for obesity. J Clin Invest (2007) 1.46

EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange. J Biol Chem (2007) 1.36

Leptin in humans: lessons from translational research. Am J Clin Nutr (2009) 1.35

Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab (2004) 1.34

The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol (2006) 1.32

Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes. Biochem Pharmacol (2009) 1.17

Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice. Arthritis Res Ther (2004) 1.12

Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab (2001) 1.12

Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice. Endocrinology (2008) 1.04

IL-17 in systemic lupus erythematosus. J Biomed Biotechnol (2010) 1.04

Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur J Immunol (2002) 1.03

A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol (2009) 0.98

Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: physiological implications. Endocrinology (1992) 0.96

Insulin-dependent adipogenesis in stromal ST2 cells derived from murine bone marrow. Biosci Biotechnol Biochem (2003) 0.92

Leptin as an endocrine signal in bone. Curr Osteoporos Rep (2008) 0.78

Acute peritonitis in a C57BL/6 mouse model of peritoneal dialysis. Adv Perit Dial (2007) 0.78

Articles by these authors

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol (2007) 10.71

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med (2009) 5.55

Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology (2010) 3.51

Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem (2003) 3.41

Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity (2009) 3.33

Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol (2004) 2.73

Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem (2006) 2.65

An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood (2007) 2.26

Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine (2008) 2.19

Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol (2004) 2.03

CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity (2011) 2.00

Th17 cells in immunity to Candida albicans. Cell Host Microbe (2012) 1.97

CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol Cell Biol (2004) 1.96

Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci U S A (2007) 1.85

Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J Biol Chem (2004) 1.77

IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol (2008) 1.73

IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J Immunol (2010) 1.69

NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One (2010) 1.69

1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol (2011) 1.67

Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci (2008) 1.60

IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci Signal (2009) 1.57

Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol (2007) 1.43

Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect (2010) 1.38

Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J Immunol (2009) 1.38

The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infect Immun (2008) 1.35

Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. Arthritis Res Ther (2012) 1.33

The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol Invest (2004) 1.31

Evidence for ligand-independent multimerization of the IL-17 receptor. J Immunol (2006) 1.29

The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling. Sci Signal (2013) 1.16

IL-17RC: a partner in IL-17 signaling and beyond. Semin Immunopathol (2009) 1.14

Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells. Mol Cells (2005) 1.13

Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J Immunol (2014) 1.13

Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor. J Immunol (2007) 1.05

CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation. J Biol Chem (2007) 1.02

SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction. J Biol Chem (2010) 1.02

Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J Immunol (2009) 1.01

A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol (2009) 0.98

IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors. Cytokine (2013) 0.94

Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Infect Immun (2013) 0.91

TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. J Immunol (2011) 0.91

The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections. Infect Immun (2013) 0.90

Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway. J Biol Chem (2008) 0.89

Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge. Eur J Immunol (2014) 0.87

The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction. PLoS One (2013) 0.86

Anti-apoptotic signaling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common gamma (gamma c) receptor subunit. J Biol Chem (2003) 0.84

Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses. Arthritis Res Ther (2014) 0.79

IL-17 signaling and A20: a balancing act. Cell Cycle (2013) 0.79

Is monocyte chemotactic protein 1 elevated in aseptic loosening of TKA? A pilot study. Clin Orthop Relat Res (2012) 0.77

Animal models for candidiasis. Curr Protoc Immunol (2014) 0.77

A competitive infection model of hematogenously disseminated candidiasis in mice redefines the role of Candida albicans IRS4 in pathogenesis. Infect Immun (2013) 0.76

Correction: Role of Neutrophils in IL-17-Dependent Immunity to Mucosal Candidiasis. J Immunol (2015) 0.75